Rifampin Capsule Shortage: FDA Update on Availability
Rifampin Capsules, an anti-infective medication, are experiencing a current shortage for certain dosages, as reported by the FDA, with some presentations available and others discontinued.
What's in Shortage
The generic drug Rifampin Capsule, also known by the brand name RIFAMPIN, is currently in shortage. It is available in capsule dosage form and belongs to the therapeutic category of Anti-Infective. The shortage was first posted on 12/22/2021 and last updated on 04/08/2026.
Which Manufacturers Are Affected
The affected manufacturer is Epic Pharma, LLC. Their availability status for various presentations includes:
- Rifampin, Capsule, 150 mg (NDC 42806-801-30): Available
- Rifampin, Capsule, 300 mg (NDC 42806-799-01): Unavailable, with related info on discontinuation of manufacture
- Rifampin, Capsule, 150 mg (NDC 42806-801-01): Unavailable, with related info on discontinuation of manufacture
- Rifampin, Capsule, 300 mg (NDC 42806-799-05): Unavailable, with related info on discontinuation of manufacture
- Rifampin, Capsule, 300 mg (NDC 42806-799-60): Available
- Rifampin, Capsule, 300 mg (NDC 42806-799-30): Unavailable, with related info on discontinuation of manufacture Contact information for Epic Pharma, LLC is (718) 276-8600 ext. 3.
Why There's a Shortage
For the unavailable presentations, the reason provided is the discontinuation of the manufacture of the drug. No specific reason was given for the overall shortage status.
What Patients Should Do
If you rely on Rifampin Capsules, we understand this can be concerning, and we encourage you to speak with your pharmacist or healthcare provider about your prescription needs. You may also contact the manufacturer for more details. Please remember, patients should always consult their healthcare provider for any medication-related concerns and not make changes without professional guidance.
Source
This information is attributed to the FDA Drug Shortages Database.
Source: FDA Official Notice